Dose interruptions of PD‐(L)1 inhibitors were observed in 2 patients (9.5%) with refractory cachexia, 2 patients (2.3%) with cachexia and 13 patients (4.3%) with pre‐cachexia (p = 0.324). This evidence concerns the gene CD274 and Cachexia.